시장보고서
상품코드
1442495

알파 아밀라아제 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 형태별, 용도별, 원료별, 지역별

Alpha Amylase Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 300 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 알파 아밀라아제 시장 규모는 2023년 18억 달러에서 2031년말에는 25억 달러로 급증할 것으로 예측됩니다.

건강과 웰니스에 관한 소비자 의식의 향상은 식품의 소비 패턴에 큰 변화를 가져오고 있습니다. 소비자의 건강지향이 높아지는 것에 따라 건강과 영양에 도움이 되는 제품을 선호하는 동향이 강해지고 있습니다. 알파 아밀라아제는 소화기계의 건강 효과와 면역계 지원으로 알려져 있으며, 이 동향에 수반하여 수요가 증가하고 있습니다. 이 시장은 보다 건강한 식품을 선택하려는 소비자 의식의 향상으로부터 혜택을 받을 태세입니다.

제약 업계에서는 면역 체계 지원, 염증 관리, 혈당 정상화 등 다양한 건강상의 이점으로 인해 알파 아밀라아제에 대한 수요가 증가하고 있습니다. 소화를 돕고 에너지를 공급한다는 것이 과학적으로 입증된 알파 아밀라아제는 소화기 질환을 치료하고 전반적인 건강을 지원하기 위한 의약품에 광범위하게 적용되고 있습니다. 좌식 생활과 건강에 해로운 식습관이 소화기 질환 증가에 기여하고 있는 가운데, 제약 부문은 알파 아밀라아제 시장 확대의 유망한 경로를 보여주고 있습니다.

유럽은 2023년 세계의 알파 아밀라아제 시장에서 28.0%의 가장 높은 물량 점유율을 기록하며 압도적인 강세를 보였습니다. 이 지역의 첨단 생명공학 산업과 광범위한 최종 사용자 기반은 시장 리더십에 기여하고 있으며, 지속적인 성장과 혁신의 무대가 되고 있습니다.

남아시아에서 알파 아밀라아제 시장은 2031년 말까지 9.4%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상되며, 이 지역은 소비자 선호도 변화와 식품 및 의약품 분야의 확장에 힘입어 시장 참여자들에게 유리한 기회를 제공할 것으로 전망됩니다.

세계의 알파 아밀라아제 시장에 대해 조사했으며, 시장의 개요와 형태별, 용도별, 원료별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장의 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나와 러시아 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 생산량과 무역통계, 2018-2023년

제4장 가격 분석, 2018-2023년

제5장 세계의 알파 아밀라아제 시장 전망, 2018-2031년

  • 세계의 알파 아밀라아제 시장 전망, 형태별, 금액(10억 달러), 수량(개), 2018-2031년
  • 세계의 알파 아밀라아제 시장 전망, 용도별, 금액(10억 달러), 수량(개), 2018-2031년
  • 세계의 알파 아밀라아제 시장 전망, 원료별, 금액(10억 달러), 수량(개), 2018-2031년
  • 세계의 알파 아밀라아제 시장 전망, 지역별, 금액(10억 달러), 수량(개), 2018-2031년

제6장 북미의 알파 아밀라아제 시장 전망, 2018-2031년

제7장 유럽의 알파 아밀라아제 시장 전망, 2018-2031년

제8장 아시아태평양의 알파 아밀라아제 시장 전망, 2018-2031년

제9장 라틴아메리카의 알파 아밀라아제 시장 전망, 2018-2031년

제10장 중동 및 아프리카의 알파 아밀라아제 시장 전망, 2018-2031년

제11장 경쟁 구도

  • 최종사용자별과 용도별 히트맵
  • 기업의 시장 점유율 분석, 2022년
  • 경쟁 대시보드
  • 기업 개요
    • Novozymes
    • Aumgene Biosciences
    • Lee BioSolutions
    • AB Enzymes
    • Infinita Biotech Private Limited
    • Jiangsu Boli Bioproducts Co., Ltd.
    • Actiza Pharmaceutical Private Limited
    • Brisk Bioscience.
    • Sisco Research Laboratories Pvt Ltd
    • Karyotica Biologicals
    • Biolaxi Corporation
    • Creative Enzymes
    • Rejoice Life Ingredients
    • Enzyme Bioscience Pvt. Ltd.
    • Sunson Industry Group Co., Ltd.

제12장 부록

KSA 24.04.04

The global alpha amylase market is set to witness robust growth in the coming years, according to a comprehensive market analysis covering the period from 2024 to 2031. The market is anticipated to surge from US$ 1.8 billion in 2023 to a staggering US$ 2.5 billion by the end of 2031. The analysis, which delves into various aspects of the market landscape, sheds light on key trends, regional insights, category-wise outlook, and competitive dynamics shaping the alpha amylase industry.

Rising Consumer Awareness Regarding Health Beneficial Products

Increasing consumer awareness regarding health and wellness is driving significant shifts in food consumption patterns. As consumers become more health-conscious, there is a growing preference for products offering enhanced health and nutrition benefits. Alpha amylase, known for its digestive health benefits and immune system support, is witnessing increased demand in line with this trend. The market is poised to benefit from this heightened consumer consciousness towards healthier food choices.

Bio-preservation Trend Fuelling Alpha Amylase Demand in Food Industry

Bio-preservation, aimed at extending the shelf life of food products through natural means, is gaining traction among consumers seeking safer and fresher food options. With artificial preservatives falling out of favor, alpha amylase emerges as a crucial component in the bio-preservation process. Its ability to maintain food freshness while meeting safety standards aligns with consumer preferences for clean label, natural products, thus driving its demand across various food sectors including dairy, beverages, and bakery.

Increasing Demand of Alpha Amylase in Pharmaceutical Industry to Bolster Sales

The pharmaceutical industry is witnessing a growing demand for alpha amylase, attributed to its various health benefits including immune system support, inflammation management, and blood sugar normalization. Scientifically proven to aid digestion and provide energy, alpha amylase is finding extensive applications in medicines aimed at addressing digestive disorders and supporting overall health. With sedentary lifestyles and unhealthy dietary habits contributing to the rise in digestive issues, the pharmaceutical sector presents a promising avenue for alpha amylase market expansion.

High Cost of Alpha Amylase to Hamper Sales

Despite its promising prospects, the high cost associated with alpha amylase remains a significant challenge for market growth. The intricate production process and sensitivity to environmental factors contribute to its expensive nature, deterring potential customers. While advancements in production methods have opened new possibilities, the premium pricing of alpha amylase continues to pose hurdles in widespread adoption.

Country-wise Insights

Europe Dominates Global Alpha Amylase Market

Europe emerges as the dominant force in the global alpha amylase market, boasting the highest volume share of 28.0% in 2023. The region's advanced biotechnology industry and extensive end-user base contribute to its market leadership, setting the stage for continued growth and innovation.

South Asia Presents Promising Growth Opportunities

In South Asia, the alpha amylase market is forecasted to exhibit substantial growth by the end of 2031. With a projected CAGR of 9.4%, the region presents lucrative opportunities for market players, fueled by evolving consumer preferences and expanding food and pharmaceutical sectors.

Category-wise Insights

Bakery Segment to Witness Steady Growth

Within the food and beverage industry, the bakery segment stands out with a projected CAGR of 8.3%. Alpha amylase's ability to enhance shelf life and improve baking volume positions it as a valuable ingredient in bakery products, driving market growth. Additionally, the demand for alpha amylase in confectionary and bio-preservation applications is on the rise, further bolstering market prospects.

Powder Form Dominates Market Share

Among different forms of alpha amylase, powder holds the largest market share, accounting for 79.3% of the global market. Its easy availability and versatility make it a preferred choice for various applications, although liquid alpha amylase is also witnessing increasing demand owing to its diverse application possibilities.

Competitive Analysis

Leading players in the global alpha amylase market, including Novozymes, Lee BioSolution, and AB Enzymes, are focusing on product diversification and research and development initiatives to maintain their competitive edge. Strategic partnerships, acquisitions, and custom manufacturing services are key strategies employed by these players to expand their market presence and cater to evolving customer needs.

The market also sees active participation from companies such as Aumgene Biosciences, Jiangsu Boli Bioproducts Co., Ltd., Ottokemi, Lee Biosolutions, Inc., and Karyotica Biologicals Pvt. Ltd., each leveraging unique capabilities and strategies to capitalize on emerging opportunities and drive innovation within the industry.

Alpha Amylase Industry Research by Category

By Form:

  • Powder & Granules
  • Liquid

By Application:

  • Food & Beverage Industry
    • Confectionery
    • Bakery
    • Brewing
    • Other Processed Food
  • Pharmaceuticals
  • Animal Feed
  • Research
  • Detergent
  • Others

By Source:

  • Bacteria
  • Fungi
  • Plants & Animals

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Alpha Amylase Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Ankle Syndesmosis Treatment Devices Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Form, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Ankle Syndesmosis Treatment Devices Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Alpha Amylase Market Outlook, 2018 - 2031

  • 5.1. Global Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Powder & Granules
      • 5.1.1.2. Liquid
  • 5.2. Global Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Food & Beverage Industry
        • 5.2.1.1.1. Confectionery
        • 5.2.1.1.2. Bakery
        • 5.2.1.1.3. Brewing
        • 5.2.1.1.4. Other Processed Food
      • 5.2.1.2. Pharmaceuticals
      • 5.2.1.3. Animal Feed
      • 5.2.1.4. Research
      • 5.2.1.5. Detergent
      • 5.2.1.6. Others
  • 5.3. Global Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Bacteria
      • 5.3.1.2. Fungi
      • 5.3.1.3. Plants & Animals
  • 5.4. Global Alpha Amylase Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Alpha Amylase Market Outlook, 2018 - 2031

  • 6.1. North America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Powder & Granules
      • 6.1.1.2. Liquid
  • 6.2. North America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Food & Beverage Industry
        • 6.2.1.1.1. Confectionery
        • 6.2.1.1.2. Bakery
        • 6.2.1.1.3. Brewing
        • 6.2.1.1.4. Other Processed Food
      • 6.2.1.2. Pharmaceuticals
      • 6.2.1.3. Animal Feed
      • 6.2.1.4. Research
      • 6.2.1.5. Detergent
      • 6.2.1.6. Others
  • 6.3. North America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Bacteria
      • 6.3.1.2. Fungi
      • 6.3.1.3. Plants & Animals
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Alpha Amylase Market Outlook, 2018 - 2031

  • 7.1. Europe Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Powder & Granules
      • 7.1.1.2. Liquid
  • 7.2. Europe Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Food & Beverage Industry
        • 7.2.1.1.1. Confectionery
        • 7.2.1.1.2. Bakery
        • 7.2.1.1.3. Brewing
        • 7.2.1.1.4. Other Processed Food
      • 7.2.1.2. Pharmaceuticals
      • 7.2.1.3. Animal Feed
      • 7.2.1.4. Research
      • 7.2.1.5. Detergent
      • 7.2.1.6. Others
  • 7.3. Europe Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Bacteria
      • 7.3.1.2. Fungi
      • 7.3.1.3. Plants & Animals
    • 7.3.2. Attractiveness Analysis
  • 7.4. Europe Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Alpha Amylase Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Powder & Granules
      • 8.1.1.2. Liquid
  • 8.2. Asia Pacific Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Food & Beverage Industry
        • 8.2.1.1.1. Confectionery
        • 8.2.1.1.2. Bakery
        • 8.2.1.1.3. Brewing
        • 8.2.1.1.4. Other Processed Food
      • 8.2.1.2. Pharmaceuticals
      • 8.2.1.3. Animal Feed
      • 8.2.1.4. Research
      • 8.2.1.5. Detergent
      • 8.2.1.6. Others
  • 8.3. Asia Pacific Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Bacteria
      • 8.3.1.2. Fungi
      • 8.3.1.3. Plants & Animals
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Alpha Amylase Market Outlook, 2018 - 2031

  • 9.1. Latin America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Powder & Granules
      • 9.1.1.2. Liquid
  • 9.2. Latin America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.2.1.1. Food & Beverage Industry
        • 9.2.1.1.1. Confectionery
        • 9.2.1.1.2. Bakery
        • 9.2.1.1.3. Brewing
        • 9.2.1.1.4. Other Processed Food
      • 9.2.1.2. Pharmaceuticals
      • 9.2.1.3. Animal Feed
      • 9.2.1.4. Research
      • 9.2.1.5. Detergent
      • 9.2.1.6. Others
  • 9.3. Latin America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Bacteria
      • 9.3.1.2. Fungi
      • 9.3.1.3. Plants & Animals
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Alpha Amylase Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Powder & Granules
      • 10.1.1.2. Liquid
  • 10.2. Middle East & Africa Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Food & Beverage Industry
        • 10.2.1.1.1. Confectionery
        • 10.2.1.1.2. Bakery
        • 10.2.1.1.3. Brewing
        • 10.2.1.1.4. Other Processed Food
      • 10.2.1.2. Pharmaceuticals
      • 10.2.1.3. Animal Feed
      • 10.2.1.4. Research
      • 10.2.1.5. Detergent
      • 10.2.1.6. Others
  • 10.3. Middle East & Africa Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Bacteria
      • 10.3.1.2. Fungi
      • 10.3.1.3. Plants & Animals
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Application Heatmap
  • 11.2. Company Market Share Analysis, 2022
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Novozymes
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Aumgene Biosciences
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Lee BioSolutions
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. AB Enzymes
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Infinita Biotech Private Limited
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Jiangsu Boli Bioproducts Co., Ltd.
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Actiza Pharmaceutical Private Limited
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Brisk Bioscience.
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Sisco Research Laboratories Pvt Ltd
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. Karyotica Biologicals
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Product Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Biolaxi Corporation
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Product Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development
    • 11.4.12. Creative Enzymes
      • 11.4.12.1. Company Overview
      • 11.4.12.2. Product Portfolio
      • 11.4.12.3. Financial Overview
      • 11.4.12.4. Business Strategies and Development
    • 11.4.13. Rejoice Life Ingredients
      • 11.4.13.1. Company Overview
      • 11.4.13.2. Product Portfolio
      • 11.4.13.3. Financial Overview
      • 11.4.13.4. Business Strategies and Development
    • 11.4.14. Enzyme Bioscience Pvt. Ltd.
      • 11.4.14.1. Company Overview
      • 11.4.14.2. Product Portfolio
      • 11.4.14.3. Financial Overview
      • 11.4.14.4. Business Strategies and Development
    • 11.4.15. Sunson Industry Group Co., Ltd.
      • 11.4.15.1. Company Overview
      • 11.4.15.2. Product Portfolio
      • 11.4.15.3. Financial Overview
      • 11.4.15.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제